First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - A survey in university hospital centers of hepatology;Erste Daten zur Versorgungssituation von Patienten mit nicht alkoholischer Fettlebererkrankung (NAFLD) in Deutschland - Eine Umfrage an universitären hepatologischen Zentren

Zeitschrift fur Gastroenterologie

Volumn 53, Issue 6, 2015, Pages 562-567

  Weiss, J ^a   Rau, M ^a   Bantel, H ^b   Bock, H ^c   Demir, M ^d   Kluwe, J ^e   Krawczyk, M ^f   Pathil Warth, A ^g   Schattenberg, J M ^h   Tacke, F ⁱ   Roeb, E ^j   Geier, A ^a   Antoni, C ^k   Berg, T ^k   Bottler T ^k   Canbay, A ^k   Denk, G ^k   Dollinger, M ^k   Mayerle, J ^k   Muche, M ^k   Schroder T ^k   Schutte K ^k   Spengler, U ^k   Teufel, A ^k   Wissniowski, T ^k   Zipprich, A ^k   more..

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f SAARLAND UNIVERSITY   (Germany)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^h UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

ⁱ UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^j UNIVERSITY HOSPITAL MARBURG   (Germany)

^k NONE

more..

Author keywords

fatty liver; Germany; medical care situation; NAFLD

Indexed keywords

ALGORITHM; ARTICLE; COMORBIDITY; DIABETOLOGIST; ENDOCRINOLOGIST; FOLLOW UP; GERMANY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH SURVEY; HOSPITAL DEPARTMENT; HUMAN; MEDICAL SERVICE; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PHYSICIAN; QUESTIONNAIRE; RISK ASSESSMENT; UNIVERSITY HOSPITAL; CLINICAL TRIAL; GASTROENTEROLOGY; HEALTH CARE SURVEY; MULTICENTER STUDY; NON-ALCOHOLIC FATTY LIVER DISEASE; PATIENT; PATIENT REFERRAL; PREVALENCE; STATISTICS AND NUMERICAL DATA; UTILIZATION; UTILIZATION REVIEW; WORKLOAD;

GASTROENTEROLOGY; GERMANY; HEALTH CARE SURVEYS; HOSPITALS, UNIVERSITY; HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE; PATIENTS; PREVALENCE; REFERRAL AND CONSULTATION; UTILIZATION REVIEW; WORKLOAD;

EID: 84935868528     PISSN: 00442771     EISSN: 14397803     Source Type: Journal    
DOI: 10.1055/s-0034-1399180     Document Type: Article

References (23)

1. Weiβ J., Rau M., Geier A. Non-alcoholic fatty liver disease - epidemiology, clinical course, investigation and treatment. Dtsch Arztebl Int: 2014; 111 447 452
2. Younossi Z. M., Stepanova M., Afendy M. et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol: 2011; 9 524 530
3. Blachier M., Leleu H., Peck-Radosavljevic M. et al. The burden of liver disease in Europe. A Review of available epidemiological data. European Association for the Study of the Liver 2013. J Hepatol: 2013; 58 593 608
4. Chalasani N., Younossi Z., Lavine J. E. et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association. Hepatology: 2012; 55 2005 2023
5. Schuppan D., Schattenberg J. M. Non-alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol: 2013; 28 68 76
6. Bataller R., Rombouts K., Altamirano J. et al. Fibrosis in alcoholic and non alcoholic steatohepatitis. Best Pract Res Clin Gastroenterol: 2011; 25 231 244
7. Agopian V. G., Kaldas F. M., Hong J. C. et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg: 2012; 256 624 633
8. Caldwell S. H., Crespo D. M. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol: 2004; 40 578 584
9. Ascha M. S., Hanouneh I. A., Lopez R. et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology: 2010; 51 1972 1978
10. Ekstedt M., Franzén L. E., Mathiesen U. L. et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology: 2006; 44 865 873
11. Adams L. A., Lymp J. F., St Sauver J. et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology: 2005; 129 113 121
12. Pomrath K., Kleiner D. E., Niemeier H. M. et al. Randomized controlled trial testing the effects of weight loss on nonalcolholic steatohepatitis. Hepatology: 2010; 51 121 129
13. Vernon G., Baranova A., Younossi Z. M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther: 2011; 34 274 285
14. Assy N., Kaita K., Mymin D. et al. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci: 2000; 45 1929 1934
15. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) Nationale Versorgungsleitlinie Therapie des Typ-2-Diabetes - Langfassung, 1. Auflage. Version 3. 2013, zuletzt geändert: April 2014. Available from: 10.6101/AZQ/000203 http://www.versorgungsleitlinien.de/themen/diabetes2 / dm2-therapie; [cited: 19.08.2014]
16. Chai S. Y., Pan X. Y., Song K. X. et al. Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone. Lipids Health Dis: 2014; 13 7
17. Finuncane F. M., Sharp S. J., Hatunic M. et al. Liver fat accumulation is associated with reduced hepatic insulin extraction and beta cell dysfunction in healthy older individuals. Diabetol Metab Syndr: 2014; 6 43
18. Stepanova M., Younossi Z. M. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin Gastroenterol Hepatol: 2012; 10 646 650
19. Sanches P. L., de Piano A., Campos R. M. et al. Association of non-alcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy. J Clin Lipidol: 2014; 8 265 272
20. Zelber-Sagi F., Lotan R., Shlomai A. et al. Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol: 2012; 56 1145 1151
21. Loria P., Adinolfi L. E., Bellentani S. et al. Prcitice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A Decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis: 2010; 42 272 282
22. Ratziu V., Bellentani S., Cortez-Pinto H. et al. A position statement on NEFLD/NASH based on EASL 2009 special conference. J Hepatol: 2010; 53 372 384
23. Farrell G. C., CHitturi S., Lau G. KK. et al. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: Executive summary. J Gastroenterol Hepatol: 2007; 22 775 777